<?xml version="1.0" encoding="UTF-8"?>
<ref id="B31-diagnostics-10-00409">
 <label>31.</label>
 <element-citation publication-type="web">
  <person-group person-group-type="author">
   <collab>INOVIO</collab>
  </person-group>
  <article-title>Completes Enrollment in the Phase 1 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine</article-title>
  <comment>Interim Results Expected in June</comment>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="http://ir.inovio.com/news-releases/news-releases-details/2020/INOVIO-Completes-Enrollment-in-the-Phase-1-US-Trial-of-INO-4800-for-COVID-19-DNA-Vaccine-Interim-Results-Expected-in-June/default.aspx" xmlns:xlink="http://www.w3.org/1999/xlink">http://ir.inovio.com/news-releases/news-releases-details/2020/INOVIO-Completes-Enrollment-in-the-Phase-1-US-Trial-of-INO-4800-for-COVID-19-DNA-Vaccine-Interim-Results-Expected-in-June/default.aspx</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-05-12">(accessed on 12 May 2020)</date-in-citation>
 </element-citation>
</ref>
